MLYS R&D Expense Growth
Mineralys Therapeutics Inc · R&D Expense Growth
MLYS R&D Expense Growth
Latest reported-21.69%period ending
MLYS FY R&D Growth (YoY) (0.00% → -21.69%)
Latest values, visible window
High-resolution chart · PNG
MLYS r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -21.694% | |
| 139.5944% | |
| 168.0419% | |
| 60.9639% | |
| 576.3998% | |
| 0% |